- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02140866
Hand Exercises for Women With Rheumatoid Arthritis and Impaired ADL Ability: an Exploratory Trial (RAHExercise)
September 19, 2017 updated by: Eva Ejlersen Wæhrens, Parker Research Institute
Hand Exercises for Women With Rheumatoid Arthritis and Impaired ADL Ability: an Exploratory Randomized Controlled Trial
The study examines whether hand exercise therapy as an add on to a compensatory intervention program focused on joint protection, assistive devices and alternative methods of doing will improve the performance of ADL tasks requiring hand function in patients with rheumatoid arthritis (RA).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
55
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Frederiksberg, Denmark, 2600
- Copenhagen University Hospital, Frederiksberg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Female sex.
- Age ≥ 18.
- Diagnosis of rheumatoid arthritis (2).
- Involvement of the hands, due to minimum one tender wrist, metacarpophalangeal (MCP) or proximal interphalangeal (PIP) joint in one of the hands.
- Be on stable medication for at least 3 months prior to participation.
- Self-reported decreased ability to perform personal and instrumental ADL tasks involving the hands.
Exclusion Criteria:
- Significant osteoarthritis of the hand assessed at the initial examination by the rheumatologist
- Hand surgery within 6 months of study participation
- Other pain condition involving muscles and/or joints, e.g. fibromyalgia.
- Prednisolon therapy, change in dose of biological agent or start of treatment with a new biological agent within the last 3 month before study start.
- Inability to understand the information or to speak Danish
- Any other condition that in the opinion of the investigator or accessing rheumatologist puts an otherwise eligible participant at increased risk by participation or otherwise make the person unfit for participation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Hand Exercise
The intervention group will receive an exercise program for the hand/arm in combination with a compensatory intervention program (CIP).
|
|
Active Comparator: Compensatory Intervention Program (CIP)
The control group will receive the Compensatory Intervention Program (CIP) only.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The Assessment of Motor and Process Skills (AMPS) - the motor skill scale
Time Frame: within 2 weeks post intervention
|
within 2 weeks post intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The Assessment of Motor and Process Skills(AMPS) - the process skill scale
Time Frame: within 2 weeks post intervention
|
within 2 weeks post intervention
|
The Activities of Daily Living Questionnaire (ADL-Q)
Time Frame: within 2 weeks post intervention
|
within 2 weeks post intervention
|
Health Assessment Questionnaire (HAQ)
Time Frame: within 2 weeks post intervention
|
within 2 weeks post intervention
|
Overall disease activity (DAS-28)
Time Frame: within 2 weeks post intervention
|
within 2 weeks post intervention
|
Grip strength
Time Frame: within 2 weeks post intervention
|
within 2 weeks post intervention
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Ultrasound Doppler
Time Frame: within 2 weeks post intervention
|
within 2 weeks post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Eva E Wæhrens, PhD, The Parker Research Institute
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2014
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
May 1, 2016
Study Registration Dates
First Submitted
May 2, 2014
First Submitted That Met QC Criteria
May 14, 2014
First Posted (Estimate)
May 16, 2014
Study Record Updates
Last Update Posted (Actual)
September 20, 2017
Last Update Submitted That Met QC Criteria
September 19, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 109
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatoid Arthritis
-
Janssen Research & Development, LLCWithdrawnActive Rheumatoid Arthritis; Rheumatoid Arthritis
-
Centocor, Inc.CompletedRheumatoid Arthritis, Juvenile
-
National Institute of Arthritis and Musculoskeletal...Children's Hospital Medical Center, CincinnatiCompleted
-
University of PittsburghNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedRheumatoid Arthritis | Juvenile Rheumatoid ArthritisUnited States
-
University of Missouri-ColumbiaCompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenTerminated
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
Universidad Autonoma de Nuevo LeonCompletedRheumatoId ArthritisMexico
-
Hamad Medical CorporationUnknownRHEUMATOID ARTHRITISQatar
Clinical Trials on Hand Exercise
-
The Arthritis Research Institute of AmericaCompletedOsteoarthritisUnited States
-
University of ManitobaCanadian Arthritis NetworkCompletedRheumatoid Arthritis | Osteoarthritis of HandsCanada
-
National and Kapodistrian University of AthensCompletedArthralgia | Systemic Lupus ErythematosusGreece
-
Changi General HospitalUnknownArteriovenous Fistula
-
Diakonhjemmet HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompleted
-
Amasya UniversityCompleted
-
Sahachat AueyingsakUnknownCardiovascular Responses in Elderly With Isolated Systolic HypertensionThailand
-
University of ManitobaUnknownStroke | HemiplegiaCanada
-
Oxford Brookes UniversityNational Institute for Health Research, United Kingdom; Royal Berkshire NHS... and other collaboratorsCompleted
-
Taipei Medical UniversityMackay Memorial HospitalNot yet recruitingMuscle Weakness | AngiogenesisTaiwan